BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11099667)

  • 1. First example of anti-Kx in a person with the McLeod phenotype and without chronic granulomatous disease.
    Russo DC; Oyen R; Powell VI; Perry S; Hitchcock J; Redman CM; Reid ME
    Transfusion; 2000 Nov; 40(11):1371-5. PubMed ID: 11099667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion support for a patient with McLeod phenotype without chronic granulomatous disease and with antibodies to Kx and Km.
    Bansal I; Jeon HR; Hui SR; Calhoun BW; Manning DW; Kelly TJ; Lee S; Baron BW
    Vox Sang; 2008 Apr; 94(3):216-220. PubMed ID: 18167163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point mutations causing the McLeod phenotype.
    Russo DC; Lee S; Reid ME; Redman CM
    Transfusion; 2002 Mar; 42(3):287-93. PubMed ID: 11961232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination of the effects of rare genotypes at the XK and KEL blood group loci results in absence of Kell system antigens from the red blood cells.
    Daniels GL; Weinauer F; Stone C; Ho M; Green CA; Jahn-Jochem H; Offner R; Monaco AP
    Blood; 1996 Nov; 88(10):4045-50. PubMed ID: 8916972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method to detect McLeod phenotype red blood cells.
    Øyen R; Reid ME; Rubinstein P; Ralph H
    Immunohematology; 1996; 12(4):160-3. PubMed ID: 15387728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. McLeod phenotype without the McLeod syndrome.
    Walker RH; Danek A; Uttner I; Offner R; Reid M; Lee S
    Transfusion; 2007 Feb; 47(2):299-305. PubMed ID: 17302777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement.
    Jung HH; Hergersberg M; Vogt M; Pahnke J; Treyer V; Röthlisberger B; Kollias SS; Russo D; Frey BM
    Transfusion; 2003 Jul; 43(7):928-38. PubMed ID: 12823753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic granulomatous disease and McLeod syndrome in a black child.
    Fikrig SM; Phillipp JC; Smithwick EM; Oyen R; Marsh WL
    Pediatrics; 1980 Sep; 66(3):403-4. PubMed ID: 7191556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic granulomatous disease and the Kell blood groups.
    Marsh WL; Oyen R; Nichols ME; Allen FH
    Br J Haematol; 1975 Feb; 29(2):247-62. PubMed ID: 1191546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A McLeod phenotype detected by random screening for K:-4 [Kp(b-)] blood donors in Brazil.
    Wendel S; Fontão-Wendel R; Levi JE; Aravechia MG; Bordokan RF; Russo D; Haddad MS
    Transfusion; 2004 Nov; 44(11):1579-87. PubMed ID: 15504163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acanthocytosis in chronic septic granulomatosis: the McLeod syndrome].
    Höger P; Seger R; Schenker T; Daniels GL; Irle U
    Monatsschr Kinderheilkd; 1985 May; 133(5):296-9. PubMed ID: 4040211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Km in a transfused man with McLeod syndrome.
    White W; Washington ED; Sabo BH; Stroup M; McCreary J; Oyen R; Marsh WL
    Rev Fr Transfus Immunohematol; 1980; 23(3):305-17. PubMed ID: 7406997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical studies on McLeod phenotype red cells and isolation of Kx antigen.
    Redman CM; Marsh WL; Scarborough A; Johnson CL; Rabin BI; Overbeeke M
    Br J Haematol; 1988 Jan; 68(1):131-6. PubMed ID: 3345289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kx antigen, the McLeod phenotype, and chronic granulomatous disease: further studies.
    Marsh WL; Oyen R; Nichols ME
    Vox Sang; 1976 Nov; 31(5):356-62. PubMed ID: 1007158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Kell blood group, Kx antigen, and chronic granulomatous disease.
    Marsh WL
    Mayo Clin Proc; 1977 Mar; 52(3):150-2. PubMed ID: 839861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary acanthocytosis associated with the McLeod phenotype of the Kell blood group system.
    Symmans WA; Shepherd CS; Marsh WL; Oyen R; Shohet SB; Linehan BJ
    Br J Haematol; 1979 Aug; 42(4):575-83. PubMed ID: 476009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kell, Kx and the McLeod syndrome.
    Redman CM; Russo D; Lee S
    Baillieres Best Pract Res Clin Haematol; 1999 Dec; 12(4):621-35. PubMed ID: 10895256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal membrane physical properties of red cells in McLeod syndrome.
    Ballas SK; Bator SM; Aubuchon JP; Marsh WL; Sharp DE; Toy EM
    Transfusion; 1990 Oct; 30(8):722-7. PubMed ID: 2219261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How we approach transfusions in a patient with high risk of alloimmunization from McLeod phenotype.
    Addams J; Hasan RA; Saifee NH
    Pediatr Blood Cancer; 2023 Feb; 70(2):e30119. PubMed ID: 36495235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigens of the Kell blood group system on neutrophils and monocytes: their relation to chronic granulomatous disease.
    Marsh WL; Uretsky SC; Douglas SD
    J Pediatr; 1975 Dec; 87(6 Pt 2):1117-20. PubMed ID: 52702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.